Delivery Order SPE2DR25D6028-SPE2DR26FASFL
Award Date 12/2/25
Potential Completion Date 12/3/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,664.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enoxaparin 40 mg/0.4 ml syringes on November 5, 2025, with completion scheduled for November 6, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime vendor contract serves...
- The Defense Logistics Agency awarded a $1,130.50 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Enoxaparin 120 mg/0.8 mL syringes. This competitively awarded, firm fixed-price contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's distribution facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,342.96 to AmerisourceBergen Drug Corp for the supply of Enoxaparin 100 mg/mL syringes on September 19, 2025. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded through the federal procurement...
- The Defense Logistics Agency awarded a $5,344.44 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Enoxaparin 40 mg/0.4 mL syringes with a completion date of November 10, 2025. This delivery order, issued without set-aside designation, represents a firm fixed price transaction for pharmaceutical products supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Enoxaparin 100 mg/ml syringes valued at $2,467.17. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for Enoxaparin Injection valued at $2,005.42 by the Defense Logistics Agency (DLA). The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through the established federal procurement process. The delivery order is scheduled for ultimate completion on November 10, 2025, with performance conducted at the contractor's Conshohocken facility. This...
- The Defense Logistics Agency awarded a $2,518.74 delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Enoxaparin 40 mg/0.4 mL syringes with an ultimate completion date of September 2, 2025. This competitive award, priced on a firm fixed-price basis with no set-aside designation, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $2,841.38 firm fixed price contract is for the supply of 100 mg/mL Enoxaparin syringes. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical...
- This is a $1,135.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 150 mg/mL enoxaparin syringes, with a period of performance through May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems....
- This contract award, valued at $1,534.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 100 mg/mL enoxaparin syringes, a critical anticoagulant medication used in military healthcare settings. The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...